We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byMadisen Joachim
Modified over 2 years ago
1 © 2004 TMIT TMIT 1 Value: Effective anti-coagulation management will be increasingly important to acute care hospital leaders. It is a key service tied to new Pay-For-Performance (P-4-P)programs, a therapy growing with our aging patient base, and one of the most frequent drugs involved in malpractice cases. There are new drugs on the horizon complicating the issue, however there are solutions that can help hospitals take an organized approach to this area. Evidence: Who benefits from such a program? The growing number of patients that are inadequately managed due to a lack of a systematic process who face disastrous consequences of preventable GI bleeding, CNS bleeding, and strokes due to clotting. Hospitals seeking to achieve the top tier performance in P-4-P: Payer programs such as the NQF Safe Practices initiative of the Leapfrog Group have identified this area as a high priority. It requires that hospitals have a systematic anticoagulation management program. What….are the key new solutions: Systematic anticoagulation Management (SAM). Originally developed through the Premier Innovation Institute, SAM has four elements: Management by qualified professional, scheduling and tracking, frequent accurate testing, and patient specific support and education. WebINR is a virtual anti-coagulation clinic, providing a web-based system for patients and physicians. Data is made available to physicians to monitor patient’s INR and provide decision support. WebINR also provides patient tracking, performance reports and patient education material at a low cost. It has demonstrated improvements of “in-range” INR values and reduced morbidity and mortality with patients. New Drug Exanta TM (Ximelagatran) is a potential replacement which does more required the same monitoring as warfarin. However, recent review by the FDA advisory panel indicates significant delay in its release. Furthermore, it is not indicated for heart valve patients which represent 1/3 of anti-coagulated patients. Where and when has this solution worked at frontline hospitals? Loma Linda VAMC has obtained great results using SAM with both reference lab and point of care testing devices – Preceptorship has been established and is open to all. El Camino Hospital – a 300 bed community hospital - has successfully implemented WebINR to monitor their patients with minimal investment Message: Why act now…why not wait…what if we pass? Act Now: In addition to preventing adverse events, and law suits a hospital has a robust anticoagulation clinic whereby a majority of the appropriate patients are managed after discharge, they will be prepared to meet future quality and P4P standards. There is still time to establish a program and receive recognition from payers and quality organizations. Wait: While certain evidence suggests that anticoagulation monitoring will not be necessary with new drugs such Exanta TM, another form of monitoring for liver enzyme levels may be required and will have to be addressed in a similar way. Hospitals that do not coordinate anticoagulation management will be at increased risk of litigation as such systematic management becomes standard of care. Pass: As time passes the risk will grow and it will be difficult for hospitals to catch up. If a competitor acts first you lose the lead role. Offering: How…..can a hospital get started? Contacts: Dr. Alan Jacobson (For Systematic Anti-coag Manag’t course) Ph 909-422-3097 firstname.lastname@example.org Jerry L. Pettis V.A. Medical Centerakjacobson@linkline.com Franck Guilloteau, CTO TMIT Ph.512-482-8888 Franck_Guilloteau@tmit1.org Resources: SAM Preceptorship – two day course at $300/person – contact Dr. Jacobson at email@example.com@linkline.com The Anticoagulation Forum (ACF) is a network of anticoagulation experts who work together to ensure safe and effective antithrombotic therapy for patients all over the country. The Anticoagulation Therapy Management Certificate Program is a six- week, 40-hour course taught five to six times per year at the University of Southern Indiana School of Nursing and Health Professions Web Sites: www.tmit1.org/PremierCEOSolutions www.acforum.orgwww.acforum.org - Anticoagulation Forum www.webinr.comwww.webinr.com – WebINR service http://health.usi.edu/anticoag/http://health.usi.edu/anticoag/ - Online Anticoagulation Therapy Management Certificate Program The CEO Solutions Series: Actionable Solutions for Senior Leaders Anti-coagulation Clinics: New Drivers – New Solutions
2 © 2004 TMIT TMIT Anticoagulation Clinics: New Drivers – New Solutions The CEO Solutions Series: Actionable Solutions for Senior Leaders
3 © 2004 TMIT TMIT Evidence Anticoagulation Management Services Anticoagulation therapy can reduce the risk for stroke by approximately 68%* Only 15% to 44% are prescribed warfarin* High impact – Strokes and Bleeds Warfarin Highly Litigated Drug New Drugs may confuse landscape *Source: Archives of Internal Medicine, 2000
4 © 2004 TMIT TMIT Evidence Payer Focus Service part of top tier requirement for Leapfrog NQF Safe Practices Leap Safe Practice with 4 th Highest Point Score in Survey 39/1000
5 © 2004 TMIT TMIT New Key Solutions…? Systematic Anticoagulation Management (SAM) Proven and Simple Minimal Hardware, software investment WebINR Bringing Patients and Physician Together New Drug Solutions Ximelagatran - Exanta TM
6 © 2004 TMIT TMIT Ongoing Patient Education Ongoing QI Direct Active Management by Qualified Health Care Provider Patient Scheduling and Tracking Accessible, Accurate, and Frequent PT/INR Testing Patient-specific Decision Support and Interaction Systematic Anticoagulation Management (SAM)
7 © 2004 TMIT TMIT WebINR Low Cost Web Based application Enables SAM – Tracking Patient, Decision Support and Education
8 © 2004 TMIT TMIT New Drug Exanta TM (Ximelagatran) Potential Warfarin Replacement with no Diet Restriction… However; Not indicated for Heart Valve Patients Recent FDA Advisory Panel vote Against release without further studies
9 © 2004 TMIT TMIT Anticoagulation Services Act Now: Minimal Investment and Great Outreach Program to the Community Meet future quality and P4P standards Delayed Action: Increased risk of lawsuits as systematic monitoring becomes standard of care. New Drugs such Exanta TM will still require some monitoring process Pass: Hospital cannot afford to “pass” - it is core to patient safety and providing quality care.
The role of Informatics in Patient Safety Dr. Sukhen Dey Indianan University Southeast.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
HM Modern Hospital Administrator The content 1.Ideal hospital CEO 2.Issues faced by Modern Hospital Administrator.
‘Preventing and treating blood clots’ The South Tees Anticoagulation Team 1.
Performance Measurement Orientation To schedule a presentation of “Performance Measurement Orientation” for your organization staff and/or collaborators,
© Copyright, Joint Commission Resources “Essentials” Joint Commission International’s Essentials of Health Care Quality and Patient Safety by Joint Commission.
FDA Risk Management Workshop: Concept Paper: Risk Management Programs April 10, 2003 Gary C. Stein, Ph.D. Director of Federal Regulatory Affairs American.
MEDICAL HOME 1/2009 Mary Goldman, D.O., President of MAOFP.
Older People with Dementia in Acute Care: K ey messages from the NAO report Paul Forte The Balance of Care Group
1 © 2004 TMIT TMIT The Leapfrog NQF Safe Practices Briefing Carol Ferguson, RN, MSN Director of Patient Safety and Performance Improvement Texas Medical.
South Tees Hospitals Hospital Discharge Bev Walker Assistant Director of Nursing and Patient Safety Patients are central to everything we do.
My Mom’s Legacy Our Mission Prevent medical errors by ensuring that patients and families have the KNOWLEDGE they need to promote a safe hospital experience.
Evolution of Clinical Psychology Tonight we will discuss the major issues surrounding the following current controversies in the field of Psychology.
Using drug use evaluation (DUE) to optimise analgesic prescribing in emergency departments (EDs) Karen Kaye, Susie Welch. NSW Therapeutic Advisory Group*
27 June 2000Victor F. C. Raczkowski, M.D.1 Risk-Management Options Victor F. C. Raczkowski, M.D., M.S. Gastrointestinal Drugs Advisory Committee 27 June.
September 10, 2008 Medication Safety: Anticoagulation Management Carla S. Huber, ARNP MS Community Anticoagulation Therapy (CAT) Clinic Cedar Rapids, IA.
Accredited by /Agréé par ISQua CCHSA Accreditation: New Standards for Managing Medications Jessica Peters Lead, Research & Product Development CCHSA.
Chronic Medication Service (CMS). Programme Introduction Pharmaceutical Care Planning - Ray ePharmacy Programme – Dawn, IM & T Workshops – Niall, Michelle,
Transforming Community Services Commissioning Information for Community Services Stakeholder Workshop 14 October 2009 Coleen Milligan – Project Manager.
Local Enhanced Service Care bundles Dr Andy Kilpatrick, Clinical Lead.
Quality and Patient Safety Council May 27, 2014 Presented By Susan M. Blackhurst BS, RN & Eric Jean BSN, RN, CCRN.
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications Mark Bleackley MEDG 505 March.
Pharmacists’ Expanded Scope of Practice in Canada as of Oct 2014 Source: Canadian Pharmacists Association.
Copyright © 2015 Cengage Learning® 1 Chapter 7 Responsibilities and Principles of Drug Administration.
Impact of Multidisciplinary Team Care on Older People with Polypharmacy Liang-Kung Chen Center for Geriatrics and Gerontology Taipei Veterans General Hospital.
Community Pharmacy Presentation for Hospital Pharmacists July 2015.
This study is funded by a contract from the National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services. Cancer.
The Commonwealth Fund 2006 International Health Policy Survey of Primary Care Physicians in Seven Countries The Commonwealth Fund 2006 International Symposium.
Legal Issues in Health Information Technology Acquisition, Implementation and Cooperation Wednesday October 20,2005 The Health Information.
Creating Customized Resident Self-Evaluation Assessments in PharmAcademic TM Andrea Weeks, PharmD PGY1 Residency Co-Director and Preceptor Paoli Hospital.
Summary of ICIUM Chronic Care Track Prepared by: Ricardo Perez-Cuevas Veronika Wirtz David Beran.
The EINSTEIN DVT Study 'Xarelto' for the Acute and Continued Treatment of Symptomatic Deep Vein Thrombosis.
Preventing Errors in Medicine. A medical error is a preventable adverse effect of care whether or not it is evident or harmful to the patient. Medical.
Promote health, prevent illness/injury Broad knowledge base needed to meet patient needs in different health care settings.
Centers of Excellence Monterey Bay Public Employees Trust Centers of Excellence 2014 Centers of Excellence are selected after careful review by.
Spotlight Case Watch the Warfarin!. 2 Source and Credits This presentation is based on the July 2011 AHRQ WebM&M Spotlight Case –See the full article.
QIO Program Overview December 6, About VHQC Private, non-profit healthcare consulting and quality improvement organization More than 60 experienced.
Liberating the NHS - A consultation on proposals Transparency in outcomes: a framework for the NHS.
Cap.org v. # Pathologists’ Role in Coordinated Care and Managing Patient Populations.
POC INR Testing Rural and Remote Session 2015 CADTH SYMPOSIUM Janice Mann MD Knowledge Mobilization, CADTH.
Dr : Osama Badry Cardiology /Anticogaulation Coordinator Incharge of Anticoagulation Service AWH-HMC/Qatar.
The State of Patient Safety in Minnesota Jennifer P. Lundblad, PhD, MBA for the BHCAG Community Forum November 11, 2010.
Let Us Bring You the Insight You Need. I need to limit risk. I need to improve quality. I need access to information. I need to make informed decisions.
Vanderbilt Pediatric Hematology Anticoagulation Guidance Protocol Robert F. Sidonio, Jr. MD, MSc. 4/12/12 Warfarin Monitoring If inpatient, consider monitoring.
New Oral Anticoagulants (NOACs) Dabigatran and Rivaroxaban for the prevention of stroke and systemic embolism in nonvalvular atrial fibrillation Educational.
The Legal Implications of Practice Guidelines Cal Chaney, JD April 12, 2002.
The Challenges for Medicines Optimisation Dr Bruce Warner, Deputy Chief Pharmaceutical Officer, NHS England.
00 Innovative Citizen-Centred Services Through Collaboration Institute for Citizen-Centred Service.
ANTICOAGULATION The objectives of this section are: To be able to write prescriptions according to local anticoagulation guidelines To know how to prescribe.
THE JOINT COMMISSION PATIENT BLOOD MANAGEMENT PERFORMANCE MEASURES TAC OCT
© 2017 SlidePlayer.com Inc. All rights reserved.